Skip to Content

APO 25 250 (Carbidopa and levodopa 25 mg / 250 mg)

Pill imprint APO 25 250 has been identified as Carbidopa and levodopa 25 mg / 250 mg.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa and levodopa 25 mg / 250 mg APO 25 250
Carbidopa and levodopa 25 mg / 250 mg APO 25 250
Discount Card Promo
Carbidopa and levodopa
APO 25 250
25 mg / 250 mg
10.00 mm
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Apotex Corporation
National Drug Code (NDC):
Inactive Ingredients:
magnesium stearate
sodium bicarbonate
FD&C Blue No. 1
FD&C Blue No. 2

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.